Agape ATP Corp (ATPC) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Jul 16, 2026
Agape ATP Corp (ATPC)
A forensic read on Agape ATP Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
F · Poor — capital at risk
Forensic grade
Safe
Financial health
14.4
Altman Z-score
Clean
Earnings quality
4
Forensic signals
Agape ATP Corp earns a F (Poor — capital at risk) forensic quality grade, and its Altman Z-score is 14.4, placing it in the Safe zone. 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-11%Return on invested capital.Return on invested capital is -11% in the latest fiscal year and rising from -180% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
+108.9%/yrShare-count dilution.Diluted share count changed +812% over the last 3 years to FY2025 (+108.9%/yr). The count is GROWING — existing holders are being diluted. That's ~108.9% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2022 has been diluted ~89%.
OCF ($2M)Shareholder returns.Returned $93,889 to shareholders (buybacks + dividends) in FY2023, while operating cash flow itself was ($2M) — zero or negative. Capex isn't disclosed for FY2023, but free cash flow can't have been positive when operating cash flow already isn't, so the entire return is coming from debt or cash reserves, not cash the business generated.
n/m (sign flip)Accruals ratio.Net operating assets flipped from negative to positive FY2024→FY2025 (FY2024 $-0.1M to FY2025 $+22.3M) — the standard accruals ratio divides by the average of the two, which collapses toward zero right as the sign changes, so the resulting percentage is a denominator artifact, not a real accrual measurement. Treat this as a structural balance-sheet shift to understand on its own terms rather than a clean or dirty accruals read.
Key fundamentals
Net Margin-149.6%
Free Cash Flow$-2.4M
Latest Revenue$1.5M
Return on Equity-10.2%
Revenue CAGR (3yr)-6.4%
Revenue Growth YoY+15.2%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Agape ATP Corp:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about ATPC's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown